Related references
Note: Only part of the references are listed.Characterization of Interplay Between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas
Lijie Chen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
Xing Niu et al.
SEMINARS IN CANCER BIOLOGY (2022)
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
Zhihao Lu et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy
Xu Zhang et al.
ACTA PHARMACEUTICA SINICA B (2022)
Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma
Ke Shi et al.
BMC CANCER (2021)
Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma
Mingxia Jiang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine
ShuangSang Fang et al.
NUCLEIC ACIDS RESEARCH (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
DHA induces Jurkat T-cell arrest in G2/M phase of cell cycle and modulates the plasma membrane expression of TRPC3/6 channels
Hamza Saidi et al.
BIOCHIMIE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
Aron Bartha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
Qingrong Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
K. Shitara et al.
ANNALS OF ONCOLOGY (2021)
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
Somnath Mukherjee et al.
EUROPEAN JOURNAL OF CANCER (2021)
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial
Huiyan Luo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Xiaotian Zhang et al.
LANCET ONCOLOGY (2021)
MicroRNA-1-3p Suppresses Malignant Phenotypes of Ameloblastoma Through Down-Regulating Lysosomal Associated Membrane Protein 2-Mediated Autophagy
Xing Niu et al.
FRONTIERS IN MEDICINE (2021)
PubChem in 2021: new data content and improved web interfaces
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2021)
Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin
Qiang Ma et al.
CHINESE MEDICINE (2020)
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Quyuan Tao et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2020)
SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway
Ruijuan Du et al.
ONCOGENE (2020)
Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
Xiao Chen et al.
ONCOLOGY LETTERS (2020)
Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
Lili Zhu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
Wei Cui et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules
Antoine Daina et al.
NUCLEIC ACIDS RESEARCH (2019)
Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2
Shumin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma
Xi Liu et al.
GASTROENTEROLOGY (2017)
Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells
Renyu Lin et al.
CANCER LETTERS (2016)
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
Zhongyang Liu et al.
SCIENTIFIC REPORTS (2016)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)